Logo

Join us as the ClinGen Somatic and VICC Virtual Molecular Tumor Board teams up with The American College of Medical Genetics and Genomics for an innovative CME case series. This series is intended as a forum to share multidisciplinary experiences in cancer genetics around the world to better understand cancer variant detection methods, genomic interpretation, and cancer patient management.

Upcoming Events:

May

28

ClinGen Somatic and VICC VMTB CME Case Presentation: Adventures in a CHIP Clinic

11:00am - 12:00pm ET

Clonal hematopoesis of indeterminate potential (CHIP) is an entity of somatic mutation related to age as well as an increased risk for development of hematologic neoplasms.  Patients with CHIP can benefit from understanding their risk for developing hematologic neoplasms and gaining access to tools for early detection of cancer and potential lifestyle changes.  Dr. Terra Lasho will discuss cases highlighting the benefits and challenges of CHIP detection and management.

July

23

 Leveraging Large Language Models for Decision Support in Personalized Oncology

11:00am - 12:00pm ET

Explore the transformative impact of Large Language Models (LLMs) in our upcoming presentation, where we assess their potential in precision oncology. By analyzing ten advanced cancer cases, we compare treatment suggestions from four LLMs and an expert physician, highlighting both innovative strategies and deviations from expert recommendations. Discover how, despite current limitations, LLMs could enhance decision-making tools in oncology and revolutionize personalized patient care as technology advances.

August

27

Liquid Biopsy Detection of a TP53 Variant in a “Disease Free” Pediatric Patient: Challenges in Interpretation

11:00am - 12:00pm ET

Explore the cutting-edge realm of liquid biopsy testing in cancer diagnostics with Drs. Patrick Blackburn and Selene Koo. This course delves into the emerging role of Plasma-derived cell-free DNA (cfDNA) testing as a non-invasive adjunct to traditional biopsies, showcasing its potential in detecting tumor variants and its application in cancer surveillance. Join us to gain invaluable insights into the advantages, limitations, and pitfalls of this revolutionary approach. Presented by Patrick R. Blackburn, PhD, FACMG, and Selene C. Koo, MD, PhD, from the Department of Pathology at St. Jude Children’s Research Hospital.

Free Educational Credits Available.

© 2024 American College of Medical Genetics and Genomics. All rights reserved.

Powered By